Loading clinical trials...
Loading clinical trials...
Longitudinal study nonrandomized, multicenter observational descriptive monitoring patients treated with anti-angiogenic for metastatic kidney cancer
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Centre Francois Baclesse
Collaborators
NCT06364631 · Metastatic Kidney Cancer, Metastatic Kidney Carcinoma
NCT02035358 · Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, and more
NCT03189186 · Renal Cell Carcinoma, Metastatic Kidney Cancer
NCT03097601 · Metastatic Kidney Cancers
NCT03846128 · Metastatic Kidney Cancer
Centre François BACLESSE
Caen, Calvados
Centre Henri Becquerel
Rouen, Seine Maritime
CHU
Rouen, Seine Maritime
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions